Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2020 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Oxidative stress and DNA damage in critically ill patients with sepsis.
Mihaljevic O, Zivancevic-Simonovic S, Jovanovic D, Drakulic SM, Vukajlovic JT, Markovic A, Pirkovic MS, Srejovic I, Jakovljevic V, Milosevic-Djordjevic O. Mihaljevic O, et al. Among authors: drakulic sm. Mutat Res Genet Toxicol Environ Mutagen. 2023 Jul;889:503655. doi: 10.1016/j.mrgentox.2023.503655. Epub 2023 Jun 30. Mutat Res Genet Toxicol Environ Mutagen. 2023. PMID: 37491118
Interleukin 33, soluble suppression of tumorigenicity 2, interleukin 27, and galectin 3 as predictors for outcome in patients admitted to intensive care units.
Eric S, Zaric RZ, Jevdjic J, Drakulic SM, Stanojevic I, Vojvodic D, Arsenijevic P, Stojanovic B, Jakovljevic S, Markovic N, Zaric M, Canovic P, Nesic J, Zornic N. Eric S, et al. Among authors: drakulic sm. Open Med (Wars). 2023 Dec 21;18(1):20230859. doi: 10.1515/med-2023-0859. eCollection 2023. Open Med (Wars). 2023. PMID: 38152329 Free PMC article.
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis.
Gold R, Kappos L, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K, Tornatore C, Sweetser MT, Yang M, Sheikh SI, Dawson KT; DEFINE Study Investigators. Gold R, et al. N Engl J Med. 2012 Sep 20;367(12):1098-107. doi: 10.1056/NEJMoa1114287. N Engl J Med. 2012. PMID: 22992073 Free article. Clinical Trial.
Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.
Fox RJ, Miller DH, Phillips JT, Hutchinson M, Havrdova E, Kita M, Yang M, Raghupathi K, Novas M, Sweetser MT, Viglietta V, Dawson KT; CONFIRM Study Investigators. Fox RJ, et al. N Engl J Med. 2012 Sep 20;367(12):1087-97. doi: 10.1056/NEJMoa1206328. N Engl J Med. 2012. PMID: 22992072 Free article. Clinical Trial.